热门资讯> 正文

Quoin Pharmaceuticals非GAAP每股收益为-6.28美元

2025-08-07 21:23

Quoin Pharmaceuticals press release (NASDAQ:QNRX): Q2 Non-GAAP EPS of -$6.28.
Quoin had approximately $7.8 million in cash, cash equivalents, and marketable securities as of June 30, 2025. The Company believes this capital will support operations into the first quarter of 2026.

More on Quoin Pharmaceuticals

Quoin Pharmaceuticals GAAP EPADS of -$6.50 misses by $2.65
Seeking Alpha’s Quant Rating on Quoin Pharmaceuticals
Historical earnings data for Quoin Pharmaceuticals
Financial information for Quoin Pharmaceuticals

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。